CYDY
CytoDyn Inc

7,085
Mkt Cap
$373.72M
Volume
2.53M
52W High
$0.4945
52W Low
$0.1031
PE Ratio
-16.26
CYDY Fundamentals
Price
$0.3027
Prev Close
$0.2959
Open
$0.2955
50D MA
$0.2654
Beta
0.46
Avg. Volume
1.77M
EPS (Annual)
$0.0018
P/B
-3.74
Rev/Employee
$0.00
Loading...
Loading...
CytoDyn, Inc. is a clinical-stage biotechnology company, which focuses on the clinical development of innovative treatments for multiple therapeutic indications based on its product candidate, leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5. Its pipeline includes Leronlimab Clinical Development Pipeline and Long-Acting CCR5 Inhibitor Development Pipeline. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13

Frequently Asked Questions

What is Market Cap of Cytodyn Inc?
What is the 52-week high for Cytodyn Inc?
What is the 52-week low for Cytodyn Inc?
What is Cytodyn Inc stock price today?
What was Cytodyn Inc stock price yesterday?
What is the PE ratio of Cytodyn Inc?
What is the Price-to-Book ratio of Cytodyn Inc?
What is the 50-day moving average of Cytodyn Inc?
How many employess does Cytodyn Inc has?

Latest CYDY News

View
No CYDY news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.